| REGISTERED NUMBER: |
| Unaudited Financial Statements |
| for the Period |
| 29 October 2024 to 31 December 2025 |
| for |
| Eye Exam (Holdings) Limited |
| REGISTERED NUMBER: |
| Unaudited Financial Statements |
| for the Period |
| 29 October 2024 to 31 December 2025 |
| for |
| Eye Exam (Holdings) Limited |
| Eye Exam (Holdings) Limited (Registered number: 14987654) |
| Contents of the Financial Statements |
| for the Period 29 October 2024 to 31 December 2025 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| Eye Exam (Holdings) Limited |
| Company Information |
| for the Period 29 October 2024 to 31 December 2025 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| Eye Exam (Holdings) Limited (Registered number: 14987654) |
| Balance Sheet |
| 31 December 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Investments | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital | 6 |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Eye Exam (Holdings) Limited (Registered number: 14987654) |
| Notes to the Financial Statements |
| for the Period 29 October 2024 to 31 December 2025 |
| 1. | STATUTORY INFORMATION |
| Eye Exam (Holdings) Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Investments in subsidiaries |
| Investments in subsidiaries are measured at cost less impairment. |
| Financial instruments |
| Financial assets and financial liabilities are recognised when the company becomes a party to the contractual provisions of the instrument. |
| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. |
| All financial assets and liabilities are initially measured at transaction price (including transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. |
| The following assets are classified as a basic financial instruments - other debtors. |
| Other debtors are measured at the amortised cost equivalent to the undiscounted amount of cash or other consideration expected to be paid or received. |
| Impairment of assets |
| Assets are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit and loss as described below. |
| Non financial assets |
| An asset is impaired when there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. |
| Financial assets |
| For financial assets carried at cost less impairment, the impairment loss is the difference between the asset's carrying amount and the best estimate of the amount that would be received for the asset if it were sold at the reporting date. |
| Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had impairment not been recognised. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the period was NIL (2024 - NIL). |
| Eye Exam (Holdings) Limited (Registered number: 14987654) |
| Notes to the Financial Statements - continued |
| for the Period 29 October 2024 to 31 December 2025 |
| 4. | FIXED ASSET INVESTMENTS |
| Shares in |
| group |
| undertaking |
| £ |
| COST |
| At 29 October 2024 |
| and 31 December 2025 |
| NET BOOK VALUE |
| At 31 December 2025 |
| At 28 October 2024 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Other debtors |
| 6. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2025 | 2024 |
| value: | £ | £ |
| Ordinary | £1 | 1,000 | 1,000 |
| 7. | PARENT COMPANY |
| The Company's immediate parent company is Optix (Group) Limited, a company registered in England and Wales and that prepares group financial statements which includes the Company. The registered office of Optix (Group) Limited is Poppleton House, Rose Avenue, Nether Poppleton, York, YO26 6RU. |
| The largest group, which includes the Company, and for which group financial statements are prepared is Evex HoldCo GmbH (formerly known as Evex AcquiCo GmbH). |